NEET MDS Lessons
Pharmacology
Class II Beta Blockers
Block SNS stimulation of beta receptors in the heart and decreasing risks of ventricular fibrillation
– Blockage of SA and ectopic pacemakers: decreases automaticity
– Blockage of AV increases the refractory period
- Increase AV nodal conduction ´
- Increase PR interval
- Reduce adrenergic activity
Treatment: Supraventricular tachycardia (AF, flutter, paroxysmal supraventricular tachycardia
– Acebutolol
– Esmolol
– Propanolol
Contraindications and Cautions
• Contraindicated in sinus bradycardia P < 45
• Cardiogenic shock, asthma or respiratory depression which could be made worse by the blocking of Beta receptors.
• Use cautiously in patients with diabetes and thyroid dysfunction, which could be altered by the blockade of Beta receptors
• Renal and hepatic dysfunction could alter the metabolism and excretion of these drugs.
Neuron Basic Structure (How brain cells communicate)
• Synapse:A junction between the terminal button of an axon and the membrane of another neuron
• Terminal button(orbouton):The bud at the end of a branch of an axon; forms synapses with another neuron; sends information to that neuron.
• Neurotransmitter:A chemical that is released by a terminal button; has an excitatory or inhibitory effect on another neuron.
Different types of Synapses
1-Axo-denrdritic
2-Axo-axonal
3-Axo-somatic
Chemical transmission in the CNS
The CNS controls the main functions of the body through the action endogenous chemical substances known as “neurotransmitters”.
These neurotransmitters are stored in and secreted by neurons to “transmit”information to the postsynaptic sites producing either excitatoryor inhibitory responses.
Most centrally acting drugs exert their actions at the synaptic junctions by either affecting neurotransmitter synthesis, release, uptake, or by exerting direct agonistor antagonistaction on postsynaptic sites.
Sulfonylureas
1st generation
tolbutamide
chlorpropamide
2nd generation
glyburide
glimepiride
glipizide
Mechanism
glucose normally triggers insulin release from pancreatic β cells by increasing intracellular ATP
→ closes K+ channels → depolarization → ↑ Ca2+ influx → insulin release
sulfonylureas mimic action of glucose by closing K+ channels in pancreatic β cells
→ depolarization → ↑ Ca2+ influx → insulin release
its use results in
↓ glucagon release
↑ insulin sensitivity in muscle and liver
Clinical use
type II DM
stimulates release of endogenous insulin
cannot be used in type I DM due to complete lack of islet function
Toxicity
first generation
disulfiram-like effects
especially chlorpropamide
second generation
hypoglycemia
weight gain
Factors affecting onset and duration of action of local anesthetics
pH of tissue
pKa of drug
Time of diffusion from needle tip to nerve
Time of diffusion away from nerve
Nerve morphology
Concentration of drug
Lipid solubility of drug
Ethosuximide (Zarontin): use in absence seizures (may exacerbate tonic-clonic seizures)
Mechanism: ↓ T-type Ca currents in thalamic neurons, inhibits bursts of APs, ↓ synchronous neuronal firing
i. Thalamo-cortical reverberating circuits: during absence type seizures, have reverberating circuits between cerebral cortex and thalamus at 3 Hz maintained by T-type Ca channels (since blocking these channels blocks the reverberating circuit)
Side effects: quite non-toxic; common= N/V and anorexia; less common = headache, sedation, photophobia
Local anesthetic selection
Local anesthetics are typically divided into 3 main categories:
short, intermediate and long acting local anesthetics.
Based on duration of the procedure and the duration of the individual agents
|
Infiltration |
Nerve block |
||
|
Pulpal |
Soft tissue |
Pulpal |
Soft tissue |
Short |
30 min |
2-3 hrs |
45 min |
2-3 hrs |
Intermediate |
60 min |
2-3 hrs |
75-90 min |
3-4 hrs |
Long |
40 min |
5-6 hrs |
3-4 hrs |
6-8 hrs |
Short acting agents
1. Mepivacaine 3 %
2. Lidocaine 2%
Intermediate acting agents
1. Lidocaine 2% 1:100000 epi
2. Lidocaine 2% 1:50000 epi
3. Mepivacaine 2% 1:20000 neocobefrin
4. Prilocaine 4%
5. Articaine 4% 1:100000 epi
Long acting agents
1. Bupivacaine 0.5% 1:200000 epi
Pharmacodynamics
Pharmacodynamics is the study of what drugs do to the body and how they do it.
Dose-Response Relationships
- Basic Features of the Dose-Response Relationship: The dose-response relationship is graded instead of all-or-nothing (as dose increases, response becomes progressively larger).
- Maximal Efficacy and Relative Potency
- Maximal Efficacy: the largest effects that a drug can produce
- Relative Potency: Potency refers to the amount of drug that must be given to elicit an effect.
- Potency is rarely an important characteristic of a drug.
- Potency of a drug implies nothing about its maximal efficacy.